Annals of Family Medicine
NOVEMBER 20, 2024
Context: The human papillomavirus (HPV) vaccine is recommended starting at age 9 to reduce risk of HPV linked squamous cell cancers, yet recent data shows that only 58.6% have been vaccinated by age 17. Secondary acceptance is agreeing to a vaccine subsequent to declining in a previous encounter.
FDA Law Blog
JUNE 7, 2021
This sentence was included in the 2016 approval of Exondys 51 for Duchenne muscular dystrophy and the 2018 approval of Andexxa for reversal of anticoagulation therapy. be “reasonably likely to predict” ultimate clinical benefit). Yesterday’s approval of Aduhelm helped answer that. So how did we get here?
FDA Law Blog
SEPTEMBER 14, 2021
For drugs approved before July 1, 2015, the baseline quarter is 1Q 2016, and for drugs approved after that date, the baseline quarter is the third full quarter after launch. The Part B rebate would exclude vaccines as well. Both the Part B and Part D rebates would be excludable from ASP and Medicaid Rebate best price.
Expert insights. Personalized for you.
130 
Let's personalize your content